Mallinckrodt reports positive efficacy results from Phase III study of pain drug

Mallinckrodt has released positive efficacy results from the Phase III clinical trial of MNK-155, an investigational extended-release oral formulation of hydrocodone and acetaminophen evaluated for the management of moderate to moderately severe acut…
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news